Davion Healthcare director King buys 10,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Davion Healthcare PLC (DAVI) director Susan M. King reported a direct purchase of 10,000 common shares at $0.098 per share on November 17, 2026. Her directly held position after the transaction was 15,000 shares. No Rule 10b5-1 plan is reported for the purchase.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
King Susan M
Role
Director
Bought
10,000 shs ($980.00)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $0.098 | $980.00 |
Holdings After Transaction:
Common Stock — 15,000 shares (Direct)
Key Figures
Shares purchased: 10,000 shares
Purchase price per share: $0.098 per share
Direct shares held after purchase: 15,000 shares
3 metrics
Shares purchased
10,000 shares
Director's direct purchase on November 17, 2026
Purchase price per share
$0.098 per share
Common stock purchase on November 17, 2026
Direct shares held after purchase
15,000 shares
Susan M. King's reported position following the transaction
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.